Key Findings

🎯 Scientists Call for Clearer Definitions in Psychedelic Therapy

Researchers are sounding the alarm about confusion in psychedelic treatment: there are no standard definitions of what constitutes "psychedelic therapy." Some studies use well-known therapy methods, others just provide support during drug experiences, and still others focus on integrating the psychedelic experience afterward. The authors propose three clear categories to distinguish when drugs work alone, when they assist existing therapy, or when they're combined with structured therapy that could work without the drug.

🧠 LSD and MDMA Rewire Brain Connections in Opposite Ways

Brain scans of healthy volunteers revealed that LSD and MDMA affect the brain's reward center (striatum) in dramatically different ways. MDMA reduced connections between emotional processing areas (limbic striatum and amygdala), while LSD increased connections between decision-making areas (associative striatum) and multiple brain regions including frontal, sensorimotor, and visual cortices. Both drugs broke down normal network boundaries, but through completely different rewiring patterns.

📊 Psilocybin Side Effects Are Under-Reported in Clinical Trials

A systematic review of psilocybin-assisted psychotherapy trials found that the quality of side-effects reporting is limited and inconsistent across studies. This creates gaps in understanding the full safety profile of these treatments, which is crucial information for patients, clinicians, and regulators as these therapies move toward wider clinical use.

🔬 Targeted Ketamine Delivery Using Ultrasound Shows Promise

Scientists developed ketamine-loaded nanoparticles that can be precisely released in specific brain regions using focused ultrasound. In depressed mice, this targeted approach improved behavioral outcomes (increased activity, better mood indicators, less despair-like behavior) while avoiding systemic side effects. The nanoparticles showed 78.25% drug loading efficiency and remained stable under storage.

💊 Ketamine and Esketamine Help Beyond Just Mood Symptoms

A systematic review examined whether ketamine treatments improve real-world functioning—like work productivity and social relationships—not just depression scores. The evidence suggests these treatments may help people get back to normal life activities, addressing the persistent work and family difficulties that often continue even when mood symptoms improve.

🎯 New Cancer Therapy Combines Psilocybin with Specialized Counseling

Researchers are testing PEARL therapy—a new approach that combines psilocybin with specialized counseling designed specifically for advanced cancer patients. The protocol includes preparation sessions, a high-dose psilocybin experience, and integration sessions, all tailored to address the unique existential and relational challenges faced by people with life-threatening illness.